Diclofenac Gel for Osteoarthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how diclofenac gel, a topical anti-inflammatory medication, can alleviate knee pain from osteoarthritis, a condition where the joint wears down. Researchers aim to identify patient characteristics that lead to better outcomes with this treatment. Participants will apply the gel to their knee daily for eight weeks and report their pain levels through questionnaires. This trial may suit those who have experienced knee pain at least 15 days a month and have been diagnosed with knee osteoarthritis via X-ray in the past two years. As an unphased trial, it offers a unique opportunity to contribute to understanding how diclofenac gel can best assist those with knee osteoarthritis.
Will I have to stop taking my current medications?
The trial requires that you stop using topical or oral NSAIDs more than 3 days per week. If you're taking blood thinners, you may need to stop, except for aspirin 81 mg daily, which is allowed.
What prior data suggests that topical diclofenac gel is safe for individuals with knee osteoarthritis?
Research has shown that diclofenac gel, when applied to the skin, is generally safe and well-tolerated. It effectively reduces knee pain from osteoarthritis and is usually gentler on the body than oral medications. For instance, one study found that the gel relieved pain with fewer side effects than oral medications. Another study confirmed its effectiveness and safety for knee pain relief over a three-week period. Although limited information exists on its long-term use in everyday life, clinical studies consistently report that diclofenac gel is a safe option for managing knee pain from osteoarthritis.12345
Why are researchers excited about this trial?
Unlike the standard oral medications and injections typically used for osteoarthritis, Diclofenac Gel offers a topical treatment option. This gel is applied directly to the affected knee, which can help reduce systemic side effects often associated with oral NSAIDs (non-steroidal anti-inflammatory drugs) like stomach issues or cardiovascular risks. Researchers are excited about this treatment because it allows for targeted pain relief right where it's needed, potentially leading to improved patient comfort and adherence.
What evidence suggests that topical diclofenac gel is effective for osteoarthritis?
Research has shown that diclofenac gel, when applied to the skin, helps relieve knee osteoarthritis pain. Studies have found that this gel significantly reduces pain and improves movement compared to a placebo, which contains no active medicine. One study found that using diclofenac gel for three weeks provided safe relief from osteoarthritis symptoms. Another report showed that it noticeably reduced pain over 8 to 12 weeks. These findings suggest that diclofenac gel could be a helpful treatment for knee osteoarthritis. Participants in this trial will apply topical diclofenac gel 1% to the index knee for 8 weeks.12456
Who Is on the Research Team?
Michelle Dossett, MD, PhD, MPH
Principal Investigator
University of California, Davis
Are You a Good Fit for This Trial?
This trial is for individuals with knee osteoarthritis who are willing to apply diclofenac gel on their knee and can attend two study visits. Participants will also need to answer biweekly questions about their knee pain and treatment usage.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Study Visit
Participants attend the first study visit to complete baseline questionnaires, have blood drawn, and receive diclofenac gel
Treatment
Participants apply topical diclofenac to their knee for 8 weeks and complete biweekly questions about knee pain and diclofenac use
Follow-up
Participants attend a follow-up visit to complete final questionnaires and assess outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Topical Diclofenac gel
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor
Beth Israel Deaconess Medical Center
Collaborator
National Institute on Aging (NIA)
Collaborator